{"result": "The APROCCHSS TRIAL, also known as the Activated Protein C and Corticosteroids for Human Septic Shock trial, was designed to evaluate the benefits and risks of corticosteroids and drotrecogin alfa (activated) in patients with septic shock. This clinical trial demonstrated a survival benefit with the use of hydrocortisone plus fludrocortisone in adults who were experiencing septic shock with persistent vasopressor dependency and organ failures. Through its comprehensive approach, the APROCCHSS TRIAL has contributed valuable insights into the management and treatment of septic shock, highlighting the potential of specific corticosteroid treatments in improving patient outcomes in this critical condition.", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"APROCCHSS TRIAL\"\nDescription List: [\"A clinical trial that showed a survival benefit with hydrocortisone plus fludrocortisone in adults with septic shock and persistent vasopressor dependency and organ failures\", \"The Activated Protein C and Corticosteroids for Human Septic Shock trial, designed to evaluate the benefits and risks of corticosteroids and drotrecogin alfa (activated) for septic shock patients\"]\n#######\nOutput:\n", "parameters": {"model": "gpt-4-turbo-preview", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": 1}, "history": null}